Total item
Cart Subtotal
$0.00 PPAR
47 Item(s)
per page
-
Pioglitazone hydrochloride
Catalog No. A16670 PPARγ agonistPioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively. Learn More -
GW1929
Catalog No. A15099 PPAR agonistGW1929 is a synthetic peroxisome proliferator-activated receptor-γ (PPARγ) agonist with IC50 of 6.2 nM and 13 nM for human and mouse, respectively. Learn More -
Balaglitazone
Catalog No. A15013 PPAR-γ partial agonistBalaglitazone is a novel partial agonist of PPAR-gamma (γ). Learn More -
BMS-687453
Catalog No. A15836 PPAR agonistBMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma in PPAR-GAL4 transactivation assays. Learn More -
Aleglitazar
Catalog No. A12492 PPAR-α/γ agonistAleglitazar is a new dual PPAR-α/γ agonist with IC50 of 2.8 nM/4.6 nM. Learn More -
Elafibranor
Catalog No. A15454 PPAR agonistElafibranor is an agonist of the peroxisome proliferator-activated Receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Learn More -
CDDO-Im
Catalog No. A16308 PPARγ AgonistCDDO-Im is a novel synthetic triterpenoid more potent than its parent compound CDDO both in vitro and in vivo; PPARγ Agonist. Learn More -
DG172 dihydrochloride
Catalog No. A16309 PPARβ/δ inverse agonistDG-172 is an orally active potent PPARβ/δ inverse agonist (IC50 = 26.9 nM). DG-172 inhibits Angptl4 gene expression in mouse myoblasts (IC50 = 9.5 nM) in vitro. Learn More -
5-Aminosalicylic Acid
Catalog No. A10570 PPARγ agonist5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. Learn More -
T0070907
Catalog No. A11588 PPAR-γ antagonistT0070907 was identified as a potent and selective PPARgamma antagonist. With an apparent binding affinity (concentration at 50% inhibition of [(3)H]rosiglitazone binding or IC(50)) of 1 nm, T0070907 covalently modifies PPARgamma on cysteine 313 in helix 3 of human PPARgamma2. Learn More -
Fonadelpar
Catalog No. A20848 PPARδ agonistFonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy. Learn More -
Tesaglitazar
Catalog No. A20891 PPAR alpha/gamma agonistTesaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist that is more potent on PPARγ than on PPARα, with EC50s of 13.4 μM and 3.6 μM for rat PPARα and human PPARα, respectively. Learn More -
Arhalofenate
Catalog No. A21135 PPARγ agonistArhalofenate (MBX 102) is a selective partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ, used for the treatment of type 2 diabetes. Learn More -
Indeglitazar
Catalog No. A21148 PPAR agonistIndeglitazar is an orally available peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma (γ). Learn More -
Inolitazone
Catalog No. A21180 PPARγ agonistInolitazone a novel high-affinity PPARγ agonist that is dependent upon PPARγ for its biological activity with IC50 of 0.8 nM for growth inhibition. Learn More -
Peliglitazar racemate
Catalog No. A21411 dual α/γ PPAR activatorPeliglitazar racemate is the racemate of Peliglitazar. Peliglitazar is a novel dual α/γ PPAR activator. Learn More -
GW 6471
Catalog No. A21934 -
GW0742
Catalog No. A14958 PPAR agonistGW0742 is a selective agonist of PPARδ with EC50 value of 1.1 nM. Learn More -
NXT629
Catalog No. A18771 PPAR-α antagonistNXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively. Learn More -
Cetaben
Catalog No. A11137 Peroxisome ProliferatorCetaben is a unique, PPARα-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology. Learn More -
Pioglitazone (Actos)
Catalog No. A11680 PPARγ agonistPioglitazone selectively stimulates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) and to a lesser extent PPAR-α. Learn More -
Rosiglitazone (BRL-49653)
Catalog No. A10807 PPAR agonistRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. Learn More -
Ciprofibrate
Catalog No. A11727 Ciprofibrate is a peroxisome proliferator-activated receptor agonist. Learn More -
Troglitazone
Catalog No. A11981 PPARγ agonistTroglitazone is a selective PPARγ receptor agonist (EC50 values are 780 and 555 nM at murine and human PPARγ receptors respectively). Learn More -
GW 7647
Catalog No. A11982 PPARα agonistGW 7647 is a potent and highly selective PPARα agonist (EC50 values are 6, 1100 and 6200 nM for human PPARα, PPARγ and PPARδ receptors respectively). Learn More -
L-165,041
Catalog No. A11983 PPARδ agonistL-165,041 is a potent PPARδ agonist (Ki = 6 nM); displays > 100-fold selectivity for both mouse and human PPARδ receptors over other subtypes. Learn More -
GW 9662
Catalog No. A11984 PPARγ antagonistGW 9662 is a selective PPARγ antagonist (IC50 values are 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively). Learn More -
Gemfibrozil (Lopid)
Catalog No. A10424 Gemfibrozil (Lopid) is a compound used to lower lipid levels. Learn More -
Chiglitazar
Catalog No. A12701 PPARα/γ dual agonistChiglitazar is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively. Learn More -
Leriglitazone
Catalog No. A18636 PPAR gamma agonistLeriglitazone is a peroxisome proliferator activated receptor (PPAR) gamma agonist. Learn More -
MA-0204
Catalog No. A19031 PPARδ modulatorMA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD). Learn More -
LJ570
Catalog No. A20081 PPARα/PPARγ dual agonistLJ570 is a PPARα/PPARγ dual agonist with EC50s of 1.05 and 0.12 μM, respectively. Learn More -
VCE-004.8
Catalog No. A18549 PPARγ and CB2 receptor dual agonistVCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity. Learn More -
Choline Fenofibrate
Catalog No. A15044 CYP2C19/CYP2B6 inhibitorCholine Fenofibrate (ABT-335) is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia. Learn More -
BR102375
Catalog No. A18849 PPAR γ agonistBR102375 is a non-TZD peroxisome proliferator-activated receptor γ (PPAR γ) full agonist for the treatment of type 2 diabetes, reveals EC50 value of 0.28?μM and Amax ratio?of 98%. Learn More -
Etofylline
Catalog No. A17491 PPAR agonistEtofylline, also known as BRN-0251760, is a peroxisome proliferator-activated receptor (PPAR) agonist used to treat respiratory and cardiovascular disorders. Etofylline is often used as a bronchodilator. Learn More -
Clofibric Acid
Catalog No. A16463 -
pirinixic acid (WY 14643)
Catalog No. A12360 -
GW 501516
Catalog No. A11437 PPARδ receptor agonistGW501516 (GW1516 or GSK-516) is a drug that acts as a PPARδ modulator. Learn More -
Bezafibrate
Catalog No. A16307 PPAR agonistBezafibrate is the first clinically tested dual and pan-PPAR co-agonist. Learn More -
GSK-3787
Catalog No. A12391 PPAR antagonistGSK-3787 is a potent and selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6). Learn More -
GSK 0660
Catalog No. A12392 PPARδ antagonistGSK 0660 is a selective PPARβ antagonist (IC50 values are 0.155, > 10 and ≥ 10 µM at PPARβ, PPARα and PPARγ respectively). Learn More -
Rosiglitazone maleate
Catalog No. A10809 PPAR agonistRosiglitazone maleate, an antidiabetic drug, works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. Learn More -
Fenofibrate
Catalog No. A10385 Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Learn More -
Fenofibric acid
Catalog No. A16001 Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides. Learn More -
GW6471
Catalog No. A12413 PPARα antagonistGW6471 is a PPARα antagonist, shown to completely inhibit GW409544-induced activation of PPARα. Learn More -
Inolitazone dihydrochloride
Catalog No. A15129 PPARγ agonistInolitazone dihydrochloride is a novel high-affinity PPARγ agonist, which activates PPARγ with an EC50 about 1/50 that of rosiglitazone and has no effect on RIE cells. Learn More
47 Item(s)
per page
FILTER BY:
Shopping Options
- Actions
-
- Inhibitor (1)
- Agonist (31)
- Antagonist (8)
- Activator (1)
- Modulator (1)
Adooq Quality Guarantee
We promise all products perform as described.